has begun an Environmental and Social Impact Assessment (ESIA) baseline study for its Khemisset Potash Project in northern Morocco.
This news follows a scoping study released late last year which evidenced that an essential feature of the Khemisset project is its “rare” combination of low capital cost to production, with post-tax cash flow projected to be $184 million per annum, and high EBITDA margins, calculated to be over 60%.
These numbers become all the more striking when considering that they also are based on the fairly conservative assumptions that current potash prices remain flat.
The ESIA baseline study is the first step in generating a detailed ESIA which would serve as the essential document for the Ministry of Mines to convert Emmersons exploration permits to a mining licence.
The company will be conducting this study along the IFC Performance Standards and the Equator Principles, which are the guidelines for “best practice in terms of environmental and stakeholder risk management.”
Emmerson has chosen Phénixa S.A.R.L, an environmental engineering firm headquartered in Morocco, to manage the baseline study. The scope of the study will include the potential impact of the Khemisset project on areas such as land uses, habitat types and climate.
Hayden Locke, CEO of Emmerson, commented on the announcement:
“We are using local consultants with extensive in country experience, having been involved in some of the largest projects in Morocco including recently delivering an ESIA and Environmental and Social Monitoring programs to support an application for a Mining Licence.
The outstanding results of the Scoping Study for Khemisset confirmed that Emmerson controls a potentially world-class development stage potash asset and has provided us with the confidence to commence the ESIA process now to ensure our accelerated development timeline remains achievable."
For more news and updates on Emmerson Plc:
SP Angel morning look at commodities and miners, featuring: Anglo Asian Mining (AAZ LN) BUY – 96p (from 108p) – Earnings update Glencore (GLEN LN) – Glencore claim record EBITDA on strong copper mine performance Landore Resources (LND LN) – BAM Gold Preliminary Economic Assessment Pan African Resources (PAF LN) – Earnings climb as operations refocus on profitable ounces Transense Technologies plc (TRT LN) – 2nd mining contract announced this week for mining heavy truck tracking & tyre pressure monitoring
In a conference call to investors and analysts, Motif Bio confirmed that the FDA had no questions over the clinical efficacy of Iclaprim. However the FDA stated it needs additional data to further evaluate the risk for liver toxicity before the NDA approval.
Five financial stories, trending today in a 70 second podcast, including: The number of people in work in the UK has continued to climb, with a record 32.6 million employed between October and December The jobless rate, remaining at 4%, is at its lowest since early 1975.